NBIX

NASDAQStock

Neurocrine Biosciences, Inc.

$128.03-1.51 (-1.17%)

52-Week Range

$87.54
$155.63

Key Stats

Market Cap

12.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Volume

457.7K

Avg Volume

1.0M

Performance

1M

-7.03%

3M

-17.06%

6M

-9.01%

YTD

-9.12%

1Y

+17.24%

3Y

+33.83%

5Y

+31.64%

Price Chart

ETF Exposure

NBIX is held by 216 ETFs

ETFFund NameWeight
PSILAdvisorShares Psychedelics ETF5.58%
MNTLTema Neuroscience And Mental Health ETF4.89%
FBTFirst Trust NYSE Arca Biotechnology Index Fund3.42%
IBRNiShares Neuroscience and Healthcare ETF3.36%
PBEInvesco Biotechnology & Genome ETF2.84%
FTGSFirst Trust Growth Strength ETF2.00%
FGSIFT Vest Growth Strength & Target Income ETF1.99%
DEFInvesco Defensive Equity ETF1.85%
POWAInvesco Bloomberg Pricing Power ETF1.85%
INVNAlger Russell Innovation ETF1.77%
BBHVanEck Biotech ETF1.75%
BULPacer US Cash Cows Growth ETF1.66%
HELXFranklin Genomic Advancements ETF1.61%
HEAL.LiShares Healthcare Innovation UCITS ETF1.52%
HAPYHarbor Human Capital Factor Unconstrained ETF (HAPY)1.48%
ROCIROC ETF1.38%
ILDRFirst Trust Innovation Leaders ETF1.33%
BBPVirtus Biotech ETF1.30%
FXHFirst Trust Health Care AlphaDEX Fund1.26%
RFGInvesco S&P MidCap 400 Pure Growth ETF1.11%
IBBiShares Biotechnology ETF1.10%
FSGSFirst Trust SMID Growth Strength ETF1.03%
XBIState Street SPDR S&P Biotech ETF1.02%
IBBQInvesco Nasdaq Biotechnology ETF0.98%
AGRWAllspring LT Large Growth ETF0.97%
AGNGGlobal X - Aging Population ETF0.84%
LNGRGlobal X Aging Population ETF0.84%
IVOGVanguard S&P Mid-Cap 400 Growth ETF0.79%
IJKiShares S&P Mid-Cap 400 Growth ETF0.75%
MDYGState Street SPDR S&P 400 Mid Cap Growth ETF0.74%
BIBProShares - Ultra Nasdaq Biotechnology0.67%
QQQJInvesco NASDAQ Next Gen 100 ETF0.66%
MRNDIQ U.S. Mid Cap R&D Leaders ETF0.65%
DSTLDistillate U.S. Fundamental Stability & Value ETF0.61%
MIDEXtrackers S&P MidCap 400 Scored & Screened ETF0.61%
FLQMFranklin U.S. Mid Cap Multifactor Index ETF0.60%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.59%
QQJGInvesco ESG NASDAQ Next Gen 100 ETF0.59%
JDOCJPMorgan Healthcare Leaders ETF0.56%
FNYFirst Trust Mid Cap Growth AlphaDEX Fund0.53%
ISCGiShares Morningstar Small-Cap Growth ETF0.46%
JKKiShares Morningstar Small-Cap Growth ETF0.46%
QLVFlexShares US Quality Low Volatility Index Fund0.45%
XJHiShares ESG Select Screened S&P Mid-Cap ETF0.45%
SMOXHorizon Small/Mid Cap Core Equity ETF0.44%
SDGiShares MSCI Global Sustainable Development Goals ETF0.43%
QVMMInvesco S&P MidCap 400 QVM Multi-factor ETF0.43%
VBKVanguard Small-Cap Growth ETF0.42%
IVOOVanguard S&P Mid-Cap 400 ETF0.40%
SPMDState Street SPDR Portfolio S&P 400 Mid Cap ETF0.39%
Page 1 of 5Next

About NBIX ETF Exposure

Neurocrine Biosciences, Inc. (NBIX) is held by 216 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.8B, NBIX is a widely held institutional stock. The stock currently trades at $128.03. Investors can gain exposure to NBIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NBIX, sorted by portfolio weight.